Company Search:
Advanced Search
Sponsored Links
Biofermin Pharmaceutical Company Limited Company Snapshot
Biofermin Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofermin Pharmaceutical Company Limited with three other companies in this sector in Japan: Koei Chemical Company, Limited (2018 sales of 18.14 billion Japanese Yen [US$161.84 million] ), Wakamoto Pharmaceutical Co., Ltd. (10.90 billion Japanese Yen [US$97.24 million] of which 51% was Medical Pharmaceutical Products), and I'rom Group Co Ltd (8.62 billion Japanese Yen [US$76.90 million] of which 73% was Smo Business).

Sales Analysis. Biofermin Pharmaceutical Company Limited reported sales of ¥10.88 billion (US$97.03 million) for the fiscal year ending March of 2018. This represents an increase of 2.4% versus 2017, when the company's sales were ¥10.62 billion. The sales level in 2018 was fairly close to the level five years ago: in 2013, Biofermin Pharmaceutical Company Limited had sales of ¥10.31 billion. Sales of Biofermin Synthetic Drugs saw an increase that was more than double the company's growth rate: sales were up 8.1% in 2018, from ¥776.50 million to ¥839.28 million. Biofermin Pharmaceutical Company Limited also saw significant increases in sales in New Biofermins (up 3.7% to ¥6.79 billion) and Biofermin Tablet (up 3.4% to ¥1.96 billion) . Not all segments of Biofermin Pharmaceutical Company Limited experienced an increase in sales in 2018: sales of Other fell 16.9% to ¥583.17 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biofermin Pharmaceutical Company Limited
  Stock Performance Chart for Biofermin Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 2,330.00
(Figures in Japanese Yen)
1 Week 0.4%   13 Weeks -0.2%  
4 Weeks -6.5%   52 Weeks -17.1%  
Biofermin Pharmaceutical Company Limited Key Data:
  Ticker: 4517 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 10,877,459,000
(Year Ending Jan 2019).
Employees: 221
  Currency: Japanese Yen Market Cap: 27,870,541,980
  Fiscal Yr Ends: March Shares Outstanding: 11,961,606
  Share Type: Common Closely Held Shares: 8,030,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.